CIK 0001557376 · Non-accelerated filer<br>Smaller reporting company
Zeo ScientifiX, Inc.
Sign in to watch- Ticker
- ZEOX
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 474180540
- Phone
- 888-963-7881
- Business address
- 3321 COLLEGE AVENUE, SUITE 246, DAVIE, FL, 33314
- Former names
- Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., BESPOKE TRICYCLES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 70 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-20 | Skycrest Holdings, LLC 10% owner | Purchase | +500 | $2.95 | $1K | 291,393 |
| 2024-11-20 | Skycrest Holdings, LLC 10% owner | Purchase | +7,289 | $2.75 | $20K | 290,893 |
| 2024-11-19 | Skycrest Holdings, LLC 10% owner | Purchase | +5,000 | $2.65 | $13K | 283,604 |
| 2024-11-18 | Skycrest Holdings, LLC 10% owner | Purchase | +10,000 | $2.59 | $26K | 278,604 |
| 2024-09-03 | Skycrest Holdings, LLC 10% owner | Purchase | +9,000 | $2.20 | $20K | 268,604 |
| 2024-08-30 | Skycrest Holdings, LLC 10% owner | Purchase | +1,000 | $2.20 | $2K | 259,604 |
| 2024-07-11 | Grey Wendy 10% owner | Grant or award · Warrant to purchase Common Stock | +350,000 | 350,000 | ||
| 2024-07-11 | Stearn Leathem S Director | Grant or award · Stock Options | +125,000 | 125,000 | ||
| 2024-07-11 | Skycrest Holdings, LLC 10% owner | Grant or award · Warrant to purchase Common Stock | +350,000 | 350,000 | ||
| 2024-07-11 | Shapiro George Craig Chief Medical Officer | Grant or award · Stock Options | +125,000 | 125,000 | ||
| 2024-07-11 | GLAUSER STEVEN JERRY Director | Grant or award · Stock Options | +125,000 | 125,000 | ||
| 2024-07-11 | Bretz Charles Luther Director | Grant or award · Stock Options | +50,000 | 50,000 | ||
| 2024-07-11 | BOTHWELL IAN T Interim CEO & CFO | Grant or award · Stock Options | +125,000 | 125,000 | ||
| 2024-04-01 | Singh Gurvinder Pal Director | Grant or award · Stock Options | +5,000 | 5,000 | ||
| 2024-04-01 | Stearn Leathem S Director | Grant or award | +62,500 | 125,000 | ||
| 2024-04-01 | Stearn Leathem S Director | Grant or award · Stock Options | +5,000 | 5,000 | ||
| 2024-04-01 | GLAUSER STEVEN JERRY Director | Grant or award | +125,000 | 258,334 | ||
| 2024-04-01 | GLAUSER STEVEN JERRY Director | Grant or award · Stock Options | +5,000 | 5,000 | ||
| 2024-04-01 | Bretz Charles Luther Director | Grant or award · Stock Options | +5,000 | 5,000 | ||
| 2023-12-19 | Leider Harry L. Chief Executive Officer | Sale | −5,248 | $1.32 | $7K | 0 |
Page 4 of 12 · 240 trades